Penile Prosthesis Market Report 2026

The penile prosthesis market size has grown strongly in recent years. It will grow from $1.49 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to limited awareness of penile prostheses, reliance on oral ed medications, social stigma around erectile dysfunction, inadequate surgical expertise, fragmented follow-up and postoperative care.

The penile prosthesis market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing preference for inflatable and malleable implants, increasing minimally invasive outpatient procedures, expansion of urology and men’s health clinics, advancements in biocompatible implant materials, rising patient awareness and demand for long-term ed solutions. Major trends in the forecast period include increasing use of ai for preoperative planning and outcome prediction, rising adoption of personalized ed therapies based on genomics, integration of cloud and big data for patient monitoring, use of iot-enabled devices for postoperative tracking, implementation of smart manufacturing in penile prosthesis production.

The rising incidence of erectile dysfunction is expected to drive the growth of the penile prosthesis market in the coming years. Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, often leading to psychological distress and relationship challenges. The increasing occurrence of ED is attributed to factors such as aging populations, lifestyle changes including physical inactivity and poor dietary habits, a growing prevalence of chronic conditions such as diabetes and hypertension, and heightened psychological stress in modern lifestyles. Penile prostheses offer a long-term therapeutic option for men with erectile dysfunction, helping restore sexual function and improve overall quality of life. For instance, in October 2024, according to Springer Nature, a Germany-based media company, an umbrella review reported that the pooled global prevalence of erectile dysfunction among men with diabetes is 65.8%. Therefore, the increasing incidence of erectile dysfunction is contributing to the growth of the penile prosthesis market.

The growing prevalence of penile diseases is also expected to propel the growth of the penile prosthesis market going forward. Penile diseases encompass a range of conditions and disorders that affect the penis. The rising occurrence of these conditions can be linked to factors such as changes in sexual behavior, inadequate hygiene practices, higher rates of sexually transmitted infections, and delays in seeking medical care. Penile prostheses are used in certain penile disease cases, including cancer, to help restore erectile function and enhance quality of life through the surgical implantation of devices that mimic natural erection mechanisms. For example, in October 2023, according to the National Library of Medicine, a US-based medical library, approximately 2,050 men in the United States were estimated to be affected by penile cancer in 2023, resulting in around 470 deaths. Therefore, the increasing prevalence of penile diseases is driving the growth of the penile prosthesis market.

Major companies operating in the penile prosthesis market are concentrating on technological advancements, particularly in the development of innovative penile prosthesis pumps, to improve ease of use, device reliability, and patient satisfaction. These pumps are designed to simplify device operation, reduce patient learning curves, and enhance overall usability. For instance, in November 2023, Boston Scientific Corporation, a US-based medical device company, received FDA approval for its TENACIO Pump component for the AMS 700 inflatable penile prosthesis. The Tenacio pump was developed to improve user interaction by addressing issues such as valve system sticking that previously required medical intervention. It features ridges that make the pump easier for patients to locate, increased separation between the pump and deflation valve for clearer identification, and a redesigned valve system to prevent sticking.

Major companies operating in the penile prosthesis market are Giant Medical., Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Mentor Corporation, Silimed, American Medical Systems Inc, Promedon S.A., Zephyr Surgical Implants, G Surgiwear Limited, SofMedica, Rigicon Inc, Advin Health Care, Penuma Penile Implant, eska medi̇cal, Titan Medical, Eska Jonas Prosthesis, Ams Urology.

North America was the largest region in the penile prosthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the penile prosthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the penile prosthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the penile prosthesis market by increasing costs of imported implants, surgical instruments, and related medical devices, particularly in North America and Europe. These tariffs have temporarily slowed adoption in hospitals and urology centers, but have also promoted domestic manufacturing, encouraged innovation in cost-effective implant designs, and strengthened supply chain resilience for ED treatment solutions.

The penile prosthesis market research report is one of a series of new reports that provides penile prosthesis market statistics, including penile prosthesis industry global market size, regional shares, competitors with a penile prosthesis market share, detailed penile prosthesis market segments, market trends and opportunities, and any further data you may need to thrive in the penile prosthesis industry. This penile prosthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Penile prostheses, commonly referred to as penile implants, are medical devices surgically inserted into the penis to help men with erectile dysfunction (ED) achieve an erection. These devices are typically considered a last-line treatment option because the procedure is invasive and carries potential risks, including infection, device failure, and tissue erosion.

The primary types of penile prostheses include inflatable penile implants and malleable penile implants. An inflatable penile implant consists of fluid-filled cylinders placed within the penis that are inflated using a pump, allowing for a more natural-appearing erection. These prostheses are manufactured using materials such as silicone, bioflex, and others, and are utilized across various healthcare settings, including hospitals, ambulatory surgery centers, urology centers, and others.

The penile prostheses market consists of sales of self-contained penile prostheses, two-piece inflatable implants and three-piece inflatable implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.